MYC antagonizes the differentiation induced by imatinib in chronic myeloid leukemia cells through downregulation of p27KIP1
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MYC antagonizes the differentiation induced by imatinib in chronic myeloid leukemia cells through downregulation of p27KIP1
Authors
Keywords
-
Journal
ONCOGENE
Volume 32, Issue 17, Pages 2239-2246
Publisher
Springer Nature
Online
2012-06-18
DOI
10.1038/onc.2012.246
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Second-Generation Tyrosine Kinase Inhibitors: The Future of Frontline CML Therapy
- (2011) H. M. Kantarjian et al. CLINICAL CANCER RESEARCH
- SKP2 Oncogene Is a Direct MYC Target Gene and MYC Down-regulates p27KIP1through SKP2 in Human Leukemia Cells
- (2011) Gabriel Bretones et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MYC in Chronic Myeloid Leukemia: Induction of Aberrant DNA Synthesis and Association with Poor Response to Imatinib
- (2011) M. Albajar et al. MOLECULAR CANCER RESEARCH
- Global Phosphoproteomics Reveals Crosstalk Between Bcr-Abl and Negative Feedback Mechanisms Controlling Src Signaling
- (2011) L. Rubbi et al. Science Signaling
- Downregulation of both p21/Cip1 and p27/Kip1 produces a more aggressive prostate cancer phenotype
- (2010) Srirupa Roy et al. CELL CYCLE
- Inhibition of cell differentiation: A critical mechanism for MYC-mediated carcinogenesis?
- (2010) Javier Leon et al. CELL CYCLE
- Novel dual Src/Abl inhibitors for hematologic and solid malignancies
- (2010) Silvia Schenone et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Transcriptional activation of Skp2 by BCR-ABL in K562 chronic myeloid leukemia cells
- (2009) Jing-Yi Chen et al. LEUKEMIA RESEARCH
- Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative disease
- (2008) A. Agarwal et al. BLOOD
- Molecular biology of bcr-abl1-positive chronic myeloid leukemia
- (2008) A. Quintas-Cardama et al. BLOOD
- Transient Potent BCR-ABL Inhibition Is Sufficient to Commit Chronic Myeloid Leukemia Cells Irreversibly to Apoptosis
- (2008) Neil P. Shah et al. CANCER CELL
- PU.1 expression is restored upon treatment of chronic myeloid leukemia patients
- (2008) Marta Albajar et al. CANCER LETTERS
- Myc's broad reach
- (2008) M. Eilers et al. GENES & DEVELOPMENT
- Chronic Myeloid Leukemia Stem Cells
- (2008) Edward Kavalerchik et al. JOURNAL OF CLINICAL ONCOLOGY
- Association Between Imatinib-Resistant BCR-ABL Mutation-Negative Leukemia and Persistent Activation of LYN Kinase
- (2008) Ji Wu et al. JNCI-Journal of the National Cancer Institute
- Myc Inhibits p27-Induced Erythroid Differentiation of Leukemia Cells by Repressing Erythroid Master Genes without Reversing p27-Mediated Cell Cycle Arrest
- (2008) J. C. Acosta et al. MOLECULAR AND CELLULAR BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started